Notes
Differential diagnosis
ENT
- Upper airway cough syndrome (postnasal drip)
-
History Exam 1st test Other tests frequent throat clearing, postnasal drip, nasal discharge, nasal obstruction or sneezing typical, halitosis mucopurulent secretions in the nasopharynx and oropharynx or cobblestone appearance of posterior oropharynx -
therapeutic trial: response to empirical therapyMore
therapeutic trial
There is no definitive test that can prove or disprove the presence of UACS; a combination of symptoms, physical examination findings, and response to therapy is required for diagnosis. [17] When a specific cause for UACS, such as allergic rhinitis or nasal polyposis, is suspected based on history and physical examination, therapy should first be directed towards those entities.
-
therapeutic trial: response to empirical therapyMore
Pulmonary
- Asthma
-
see our comprehensive coverage of Asthma in adults
History Exam 1st test Other tests wheezing, chest tightness, dyspnoea, symptom variability, strong FHx of asthma/atopic disease, cough, paroxysms, exacerbation by irritants or seasonal exposures; cough may sometimes be the sole symptom (cough-variant asthma) [8] wheezing and prolonged expiratory phase on pulmonary examination -
spirometry with bronchodilator: reversible obstructive ventilatory defect; increase in FEV1 with bronchodilator 12% or more from baseline or 10% or more of predicted FEV1; FEV1/FVC <80% [19] More
spirometry with bronchodilator
Spirometry can be normal in some patients. If normal, bronchoprovocation testing is recommended.
-
morning vs midday peak expiratory flow (PEF) recording: variability >20%More
morning vs midday peak expiratory flow (PEF) recording
PEF should be measured in patients with normal spirometry. Variability of airway obstruction can be used to support the diagnosis of asthma. [19]
-
exhaled nitric oxide (ENO): elevatedMore
exhaled nitric oxide (ENO)
Elevated ENO is not specific enough to diagnose asthma without further testing; however, in an untreated patient, absence of elevated ENO would make asthma unlikely. [24]
-
bronchoprovocation testing: provocative concentration of methacholine causing a 20% fall in FEV1 (PC20) <4 mg/mLMore
bronchoprovocation testing
Increased airway responsiveness is a sensitive but not specific feature of asthma. Negative methacholine challenge while not receiving inhaled corticosteroids essentially excludes asthma. [25]
-
spirometry with bronchodilator: reversible obstructive ventilatory defect; increase in FEV1 with bronchodilator 12% or more from baseline or 10% or more of predicted FEV1; FEV1/FVC <80% [19] More
- Non-asthmatic eosinophilic bronchitis (NAEB)
-
History Exam 1st test Other tests chronic non-productive cough; no differentiating features on hx no differentiating features on examination -
sputum or broncho-alveolar lavage (BAL) differential count: eosinophiliaMore
sputum or broncho-alveolar lavage (BAL) differential count
Eosinophilia in sputum or BAL without obstruction on spirometry, without peak flow variability or hyperreactivity on bronchoprovocation testing, suggests NAEB. [27]
-
exhaled nitric oxide (ENO): elevatedMore
exhaled nitric oxide (ENO)
Sensitive in patients not treated with inhaled corticosteroids. [28]
-
therapeutic response to inhaled steroids: presentMore
therapeutic response to inhaled steroids
Cough due to NAEB improves after a course of inhaled steroids for 4-6 weeks.
-
sputum or broncho-alveolar lavage (BAL) differential count: eosinophiliaMore
- Chronic bronchitis
-
see our comprehensive coverage of COPD
History Exam 1st test Other tests hx of smoking may be present; cough may produce sputum; dyspnoea, especially exertional, may accompany the cough mild cases: most respiratory examinations are normal, may show quiet breath sounds, prolonged expiratory phase, rhonchi, or wheezes; advanced cases: cyanosis, barrel chest, use of accessory muscles of inspiration, increased S2 over left sternal border, or peripheral oedema -
PFT: decreased FEV1, FEV1/FVC <70%, residual volume >120%, total lung capacity >120%, diffusion capacity for CO <80%More
PFT
Spirometric, lung volume, and diffusion capacity may be present in different combinations depending on the clinical presentation.
- CXR: hyperinflation, but may not be present in some cases
-
PFT: decreased FEV1, FEV1/FVC <70%, residual volume >120%, total lung capacity >120%, diffusion capacity for CO <80%More
- Lung cancer
-
see our comprehensive coverage of Non-small cell lung cancer
History Exam 1st test Other tests hx of tobacco smoking, change in character of chronic cough, haemoptysis, hoarseness, chest pain, weight loss, superior vena cava syndrome (localised oedema of face and upper extremities, facial plethora, distended neck and chest veins), symptoms related to distant metastases and advanced stages of cancer central lung cancers may cause unilateral localised wheezing; superior vena cava syndrome; cachexia and symptoms related to distant metastases (e.g., bone pain) are late symptoms - CT chest: presence of the lesion and loco-regional disease
- sputum cytology: may document presence of malignant cells
-
bronchoscopy: presence of tumourMore
bronchoscopy
Allows visualisation of extent of tumour and collection of material for biopsy.
- Bronchiectasis and chronic suppurative lung disease
-
see our comprehensive coverage of Bronchiectasis
History Exam 1st test Other tests cough productive of large amounts of mucopurulent sputum, diurnal variation (e.g., worse in the morning), positional worsening; dyspnoea, wheezing, haemoptysis; paroxysmal cough non-productive of sputum may sometimes be present crackles and wheezing, predominantly over lower lobes; clubbing in a minority of patients -
CXR: increased bronchovascular markingsMore
CXR
Sensitive but not specific finding. Should be the first examination if high-resolution CT not available.
-
high-resolution CT chest: dilations of the bronchi, size of the bronchi exceeding the size of the accompanying artery More
high-resolution CT chest
Should be the first examination if available.
- PFT: irreversible obstructive defect, with FEV1/FVC <70%
-
CXR: increased bronchovascular markingsMore
- Interstitial pulmonary fibrosis
-
History Exam 1st test Other tests dyspnoea of sub-acute onset dominates the clinical picture; cough typically dry dry, velcro crackles, typically over lung bases; clubbing may be present -
CXR: increased interstitial markingsMore
CXR
First test if high-resolution CT not available.
-
high-resolution CT chest: interstitial pneumonitis: patchy, predominantly basilar and sub-pleural reticular changes with honeycombing and traction bronchiectasis in later stages of the diseaseMore
high-resolution CT chest
Confirmatory, sensitive and specific. Findings depend on specific interstitial pathology. Interstitial pneumonitis is the most common form.
- PFT: restrictive pattern with total lung capacity <80%, functional residual capacity <80%, and vital capacity <80%, with diffusion capacity for CO <80%
- biopsy: pattern of usual interstitial pneumonia
-
CXR: increased interstitial markingsMore
- Sarcoidosis
-
see our comprehensive coverage of Sarcoidosis
History Exam 1st test Other tests most patients asymptomatic; symptomatic patients: shortness of breath, dyspnoea on exertion, and chest pain are present in minority of patients; low-grade fever; other symptoms reflect involvement of various organs most often normal; skin lesions (erythema nodosum and maculopapular skin lesions), enlargement of lacrimal glands, lymphadenopathy in cervical, supraclavicular, or axillary areas; redness of eye, tearing, and photophobia may represent uveitis -
CXR: various findings, bilateral hilar and mediastinal lymphadenopathy, reticular infiltrates; fibrosis with decreased lung volumes in late sarcoidosisMore
CXR
Severity of radiographic lung involvement may not correlate with severity of physiological deficit.
- chest CT with high-resolution cuts: bilateral hilar and mediastinal lymphadenopathy, interstitial infiltrates
-
PFTs (spirometry, lung volumes, diffusion capacity): often normal, but may show non-specific reduction in diffusion capacity, obstruction, restriction, or mixed picture More
PFTs (spirometry, lung volumes, diffusion capacity)
Not sensitive or specific for this disorder, but results may influence therapeutic choices once coupled with clinical and radiographic data
-
bronchoscopy with biopsy: non-caseating granuloma is supportive, but other granulomatous disorders should be reasonably excluded with special stains and clinical assessmentMore
bronchoscopy with biopsy
When pulmonary involvement is present, has a high sensitivity.
-
CXR: various findings, bilateral hilar and mediastinal lymphadenopathy, reticular infiltrates; fibrosis with decreased lung volumes in late sarcoidosisMore
- Hypersensitivity pneumonitis
-
see our comprehensive coverage of Hypersensitivity pneumonitis
History Exam 1st test Other tests occupational/environmental exposure to allergens (e.g., farmers, bird breeders), progressive dyspnoea, fatigue, and weight loss clubbing, increased respiratory rate, inspiratory crackles over lower lung fields - CXR: fibrotic changes; loss of lung volume particularly affecting the upper lobes
- chest CT: features of fibrosis
- Bronchiolitis
-
see our comprehensive coverage of Bronchiolitis
History Exam 1st test Other tests age <1 year, cough, wheeze, and dyspnoea, hx of prematurity, underlying cardiopulmonary disease or immunodeficiency high respiratory rate, accessory muscle use, retractions, wheezes, crackles, purulent secretions on bronchoscopy - CXR: consolidation and atelectasis in severe disease
-
virology: may be positive for respiratory syncytial virusMore
virology
Rarely useful in making management decisions.
- high-resolution CT scan: signs of small airways disease
Gastrointestinal
- Gastro-oesophageal reflux disease (GORD)
-
see our comprehensive coverage of Gastro-oesophageal reflux disease
History Exam 1st test Other tests heartburn, dysphagia, acid regurgitation, association of cough with slouched posture, phonation, rising from bed, or eating suggest reflux disease; may be silent [18] no differentiating features on examination -
therapeutic trial of double-strength proton-pump inhibitors (PPIs) for 8 weeks: alleviation of symptoms may require 8 weeks of double-strength PPI therapy, so the trial should not be considered 'negative' before 8 weeks More
therapeutic trial of double-strength proton-pump inhibitors (PPIs) for 8 weeks
-
24-hour oesophageal pH monitoring: pH <4 for 4% or more of monitoring time and coinciding with cough is consistent with pathological acid exposure More
24-hour oesophageal pH monitoring
Most sensitive and specific for reflux disease-related cough. Testing first may be considered as an alternative to a PPI trial. Controversy exists in this regard. [26] Testing should be performed if a PPI trial does not resolve symptoms but GORD is still considered likely. A detailed assessment of symptom correlation with reflux events is most supportive of the diagnosis. [26]
-
barium oesophagram: refluxMore
barium oesophagram
Not sensitive.
-
therapeutic trial of double-strength proton-pump inhibitors (PPIs) for 8 weeks: alleviation of symptoms may require 8 weeks of double-strength PPI therapy, so the trial should not be considered 'negative' before 8 weeks More
Iatrogenic
Infectious
- Pneumonia
-
see our comprehensive coverage of Overview of pneumonia
History Exam 1st test Other tests fever, malaise, cough, usually productive of sputum, chest pain dullness to percussion, decreased breath sounds, and presence of rales - CXR: infiltrate suggestive of pneumonia
- WCC (blood): usually elevated but non-specific
- sputum Gram stain and culture: presence of micro-organisms and leukocytes in a good sputum sample (<25 squamous epithelial cells per field) supports the diagnosis of respiratory tract infection
- Post-infectious cough
-
History Exam 1st test Other tests cough of duration between 3 and 8 weeks following symptoms of acute respiratory infection; nasal/sinus congestion, non-purulent nasal discharge, sore throat [31] normal CXR; diagnosis is clinical and one of exclusion - CXR: normal, rules out pneumonia
- WCC (blood): usually elevated but non-specific
- sputum Gram stain and culture: presence of micro-organisms and leukocytes in a good sputum sample (<25 squamous epithelial cells per field) supports the diagnosis of respiratory tract infection
- Tuberculosis
-
see our comprehensive coverage of Pulmonary tuberculosis
History Exam 1st test Other tests residence in/visit to high-prevalence area, close contact with active TB; hx of anorexia, malaise, weight loss, fever, or night sweats; chronic cough productive of sputum, occasionally associated with haemoptysis; immunosuppressed status, especially AIDS fever, cachexia, tachycardia; asymmetry in chest movement and dullness to percussion due to pleural effusion, bronchial breathing, crackles, rales due to an infiltrate or rhonchi in presence of significant bronchial purulence; palpable extra-thoracic lymphadenopathy is uncommon -
CXR: primary TB: mid-lung infiltrate; secondary TB: predominantly upper lobe infiltrates with distinct tendency for fibrosis and volume lossMore
CXR
Calcified parenchymal and hilar lymph node granulomata may support the diagnosis; pleural effusion may accompany both primary and secondary TB.
-
sputum Gram stain and culture: presence of acid-fast bacilli (Ziehl-Neelsen stain) in sputum or broncho-alveolar lavage (BAL) More
sputum Gram stain and culture
Culture of Mycobacterium tuberculosis typically takes several weeks (up to 8); decisions on treatment are usually made before culture results are known.
-
tuberculin skin test: positiveMore
tuberculin skin test
Reactivity to intra-dermal injection of tuberculin is primarily used to detect latent TB, but may be used as an adjunct in diagnosis of active TB.
-
QuantiFERON: positiveMore
QuantiFERON
Detection of lymphocytes reacting to tuberculin in vitro is primarily used to detect latent TB, but may be used as an adjunct in diagnosis of active TB.
-
CXR: primary TB: mid-lung infiltrate; secondary TB: predominantly upper lobe infiltrates with distinct tendency for fibrosis and volume lossMore
- Bordetella pertussis infection
-
see our comprehensive coverage of Pertussis
History Exam 1st test Other tests paroxysms of cough, post-tussive vomiting, or inspiratory whooping sound; more likely if local epidemiology suggests increased prevalence petechiae and conjunctival haemorrhages may result from cough paroxysms; lung examination is typically normal -
nasopharyngeal culture (if symptoms <2 weeks): positiveMore
nasopharyngeal culture (if symptoms <2 weeks)
In presence of symptoms, pertussis should be diagnosed using appropriate tests when available, unless another diagnosis is proven. [31] Patient should be isolated for 5 days and case reported to public health authorities. Enriched media is required for culturing.
- rapid PCR, and/or serology (if symptoms present >4 weeks): positive
-
nasopharyngeal culture (if symptoms <2 weeks): positiveMore
- Tropical filarial pulmonary eosinophilia
-
History Exam 1st test Other tests Travel to endemic area (sub-Saharan Africa, Indian subcontinent, southeast Asia, Oceania); dry, paroxysmal cough, frequently nocturnal Frequently normal; wheezing, rhonchi, crackles may be present on lung exam; some patients develop hepatosplenomegaly - blood count with differential: eosinophilia
- CXR: increased interstitial markings
- filarial antibody levels: elevated
- serum IgE: elevated
Mechanical
- Foreign body
-
see our comprehensive coverage of Foreign body aspiration
History Exam 1st test Other tests abrupt onset, more common in young children may be asymptomatic or show signs of airways obstruction, including cough, wheeze, decreased breath sounds, dyspnoea, or fever - laryngoscopy/bronchoscopy: visualisation of foreign body
- CXR: visualisation of foreign body (if object is radio-opaque)
- chest CT: visualisation of foreign body
Neurological
- Recurrent aspiration
-
see our comprehensive coverage of Acute aspiration
History Exam 1st test Other tests dysphagia, association of cough with eating/drinking, fear of choking with eating/drinking; may have hx of neurological disease including stroke, multiple sclerosis, Parkinson's disease signs of neurological disease such as stroke, multiple sclerosis, Parkinson's disease
